CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Author
Bahlis Nizar J
+26Â more
Baker Bartrum W
Berg Deborah T
Buadi Francis K
Cavo Michele
Di Bacco Alessandra
Ganly Peter
Garderet Laurent
Gimsing Peter
Grzasko Norbert
Hansson Markus
Hui Ai-Min
Jackson Sharon R
Kumar Shaji
Laubach Jacob P
Lin Jianchang
Masszi Tamás
Moreau Philippe
Palumbo Antonio
Pour Ludek
Richardson Paul G
Sandhu Irwindeep
Simpson David R
Stoppa Anne-Marie
TOURMALINE-MM1 Study Group
Touzeau Cyrille
van de Velde Helgi
Publication venue
'Massachusetts Medical Society'
Publication date
01/01/2016
Field of study
Get PDF
Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma
Crossref
Archivio istituzionale della ricerca - Alma Mater Studiorum UniversitĂ di Bologna
DIAL UCLouvain
Open Access Repository